☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Roxadustat
Astellas and FibroGen's Evrenzo (roxadustat) Receive EC's Approval for Symptomatic Anemia Associated with Chronic Kidney Disease
August 20, 2021
PharmaShots Interview: FibroGen's Peony Yu Shares Insight on Roxadustat
December 7, 2020
PharmaShots Interview: AstraZeneca's Global Medicine Leader John Houghton Shares Insights on Roxadustat in Treating Patients with...
November 12, 2019
Load more...
Back to Home
Modal title
×
Modal body text goes here.